<p><a href="http://www.kyeongin.com/main/view.php?key=20230816010003087" target="_blank" class="ke-link">http://www.kyeongin.com/main/view.php?key=20230816010003087</a></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="분당차병원 `3D 하이브리드 단백질 이용 퇴행성 디스크 치료제 개발`" data-og-description="차의과학대학교 분당차병원(원장·윤상욱)은 16일 ``신경외과 한인보 교수가 미국 럿거스(Rutgers) 대학교 이기범 교수팀과 항염증반응이 있는 약물(bromodomain and e.." data-og-host="www.kyeongin.com" data-og-source-url="http://www.kyeongin.com/main/view.php?key=20230816010003087" data-og-url="http://www.kyeongin.com/main/view.php?key=20230816010003087" data-og-image="https://scrap.kakaocdn.net/dn/LUww6/hyTFjX8awq/s0tkGM4LTBrGPquGSBwtCK/img.jpg?width=532&height=700&face=171_185_328_356,https://scrap.kakaocdn.net/dn/bqOEqV/hyTCxDIWGq/Fk6VrZFQVLHnZWNTeAWhH1/img.jpg?width=532&height=700&face=171_185_328_356,https://scrap.kakaocdn.net/dn/QQ0Gl/hyTFn0wYLd/jgi5mVpEX4NyAh5oZbnwBk/img.jpg?width=256&height=256&face=0_0_256_256"><a href="http://www.kyeongin.com/main/view.php?key=20230816010003087" target="_blank" data-source-url="http://www.kyeongin.com/main/view.php?key=20230816010003087"><div class="og-image"><img src="https://scrap.kakaocdn.net/dn/LUww6/hyTFjX8awq/s0tkGM4LTBrGPquGSBwtCK/img.jpg?width=532&height=700&face=171_185_328_356,https://scrap.kakaocdn.net/dn/bqOEqV/hyTCxDIWGq/Fk6VrZFQVLHnZWNTeAWhH1/img.jpg?width=532&height=700&face=171_185_328_356,https://scrap.kakaocdn.net/dn/QQ0Gl/hyTFn0wYLd/jgi5mVpEX4NyAh5oZbnwBk/img.jpg?width=256&height=256&face=0_0_256_256" alt="" xxonerror="this.src="//img1.kakaocdn.net/thumb/C200x200/?fname=https%3A%2F%2Ft1.daumcdn.net%2Fcafe_image%2Fcafe_meta_image_190529.png""></div><div class="og-text"><p class="og-title">분당차병원 `3D 하이브리드 단백질 이용 퇴행성 디스크 치료제 개발`</p><p class="og-desc">차의과학대학교 분당차병원(원장·윤상욱)은 16일 ``신경외과 한인보 교수가 미국 럿거스(Rutgers) 대학교 이기범 교수팀과 항염증반응이 있는 약물(bromodomain and e..</p><p class="og-host">www.kyeongin.com</p></div></a></div><p> </p>
<!-- -->
